Deviation management refers to the process of identifying, documenting, evaluating, and addressing departures from approved study protocols, standard operating procedures (SOPs), or good clinical practice (GCP) guidelines in clinical research. It involves systematically tracking and resolving any unplanned or unintended variations that occur during the course of a clinical trial.
The primary goal of deviation management is to maintain the integrity of the study data and ensure patient safety. This process typically includes steps such as immediate reporting of deviations, root cause analysis, implementation of corrective and preventive actions (CAPA), and ongoing monitoring to prevent recurrence of similar deviations in the future.
Deviation management is crucial in clinical research as it helps maintain the scientific validity and regulatory compliance of clinical trials. By systematically addressing protocol deviations, researchers can ensure the quality and reliability of study data, which is essential for drawing accurate conclusions about the safety and efficacy of investigational products.
Furthermore, effective deviation management contributes to patient safety by promptly identifying and mitigating potential risks associated with protocol deviations. It also demonstrates to regulatory authorities and sponsors that the research team is diligent in following established procedures and capable of adapting to unforeseen circumstances, which enhances the overall credibility of the study.
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
Copyright @ 2026 Axcellant